Business Wire

Grimaldi’s Pizzeria Announces International Development Agreement for Expansion into United Arab Emirates


Grimaldi’s Pizzeria announced today, the company plans to expand internationally by opening five of its world-famous, coal-fired, brick-oven pizzerias in the United Arab Emirates over the next five years. Partnering with Tablez Food Company to ensure a seamless expansion, this international franchise agreement represents Grimaldi's first brand expansion beyond North America.

Tablez Food Company, an entity specializing in the development of unique food and beverage concepts, was the premiere partner of choice for Grimaldi’s due to its vast experience in international expansion efforts in the region with other notable franchise ventures. Grimaldi’s Pizzeria, one of the most awarded pizzerias in the United States and the only upscale pizzeria to be bestowed the coveted Five Star Diamond Award, represents the first and only pizza concept in Tablez's renowned portfolio.

“Since its inception, Grimaldi's has been singularly focused on serving exemplary food to its guests. That is why we recognized this international franchise opportunity as being an ideal partnership,” explained Grimaldi's Pizzeria CEO Joseph Ciolli. “Not only will we be able to treat new UAE customers to a truly uncompromised, coal-fired New York pizza experience, but also benefit from the reassurance that comes from working with Tablez, far and away the UAE's finest food and beverage group.”

“Our vision of becoming the UAE's leading player in the food & beverage retail sector is clearly furthered by this partnership,” said Tablez Food Company CEO Shafeena Yusuff Ali. “By bringing a world-class brand like Grimaldi's Pizzeria to the region, our customers will enjoy a truly unique offering of great tasting coal-fired pizza, made with the freshest, high-quality ingredients. Grimaldi's brings a long-standing reputation for excellence – and it is that consistency of product and passion that makes it the ideal brand to introduce to UAE.”

Beyond the Middle East, Grimaldi’s Pizzeria has engaged other investment groups in key growth markets around the globe in an effort to secure multi-unit franchise partners to introduce and develop the brand in regions including Southeast Asia, South America, Central America, Europe, Mexico, Canada and Australia.

For more information on Grimaldi’s Pizzeria’s international expansion efforts, visit:

To learn more about international franchise opportunities with Grimaldi’s Pizzeria, visit:

To inquire about becoming an international franchisee, click here:

About Grimaldi’s Pizzeria

Founded in Brooklyn, New York, Grimaldi’s Pizzeria has been consistently chosen as America's undisputed favorite coal-fired pizza offering. From its 1200-degree coal-fired ovens that deliver impeccable pies and calzones, topped or filled with the freshest ingredients, Grimaldi's has seen its enthusiastic customers support drive expansion to 50 company-owned restaurants across the United States. The brand's signature coal-burning ovens produce a unique flavor and crust crispness that is just not possible from gas, convection, or wood burning methods. Grimaldi's contends that their ongoing brand success correlates directly with three simple principles – People, Product and Service. For more information, please visit

About Tablez

Tablez Food Company is the F&B arm of the prestigious Lulu International Group LLC; a highly diversified group headlined by the retail division with presence in Imports & Exports, Trading, Shipping, IT, Travel & Tourism, Hotels, Mall Development, Hyper Markets and Education in addition to F&B in the present day.

Established in 2010, Tablez Food Company specializes in unique home grown, international and local cuisines as well as partnering with leading franchising concepts with renowned success and exceptional food quality. The company dedicates itself to creativity and innovation by bringing new concepts that offer truly inspiring dining experiences to their guests. Currently, Tablez operates 35 outlets in the region with concepts including Peppermill, Bloomsbury’s, London Dairy, Famous Dave’s BBQ, Cold Stone Creamery®, Sugar Factory, Galito’s and Genghis Grill. Tablez will continue to see a series of new food concept launches over the next two years. For more information, visit

Contact information

Preferred Public Relations
Emma Williams, 702-254-5704
Grimaldi's Pizzeria
Investor Relations
David Fieramosca, 702-927-9485

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

Seoul Semiconductor’s SunLike Series LEDs Win Product of the Year Award from Elektronik Magazine23.3.2018 18:28Pressemelding

Seoul Semiconductor, a global innovator of LED products and technology, announced on March 23rd that its SunLike Series natural spectrum LED product won the Gold Award at the Elektronik Product of the Year 2018 Awards, hosted by Elektronik (, a leading German electronics publication. This press release features multimedia. View the full release here: Product of the Year Award from Elektronik Magazine (SunLike) (Photo: Business Wire) As a publication specializing in electrical and electronic components, “Elektronik” is a prestigious magazine with an illustrious history and the largest number of subscribers in Germany. Over the past 20 years, they have conducted annual surveys among their subscribers to find the “most creative and innovative products.” Based on these survey results, Elektronik selects the top product that with the most impact in its corresponding field, and confers the awards accordingl

Elliott Welcomes Imminent Bezeq Board Overhaul and New Era for Strong Independent Governance23.3.2018 16:05Pressemelding

Elliott Advisors (UK) Limited (“Elliott”), which advises funds which collectively hold a significant economic interest in Bezeq The Israeli Telecommunication Corporation Ltd. (“Bezeq” or the “Company”), welcomes the proposed governance reforms announced by Bezeq last night. In its initial letter to Bezeq Interim Chairman David Granot, dated January 16, 2018, Elliott outlined the urgent need to address the Company’s serious corporate governance issues, and called for changes at the Board level that result in “the right mixture of expertise, independence and integrity for the future.” Elliott stated then, and reiterates now, its belief that “there is significant value to be unlocked if the right steps are taken to improve its corporate governance.” Bezeq has strong business fundamentals, an exemplary workforce, and great potential. Following yesterday’s announcement, Elliott highlights the changes that have occurred since January 16th. Taken together, these amount to a revolution in the

Clovis Oncology Initiates Early Access Program for Rucaparib as Treatment and as Maintenance Therapy in Recurrent Ovarian Cancer in Europe23.3.2018 12:52Pressemelding

Clovis Oncology, Inc. (NASDAQ:CLVS) today announced the initiation of an early access program in Europe for rucaparib for treatment and as maintenance therapy in recurrent ovarian cancer. The program will be overseen and implemented by Caligor Coghlan, which specializes in early access to medicines. The program, to be known as the Rucaparib Access Program (RAP), will enable participation from certain countries in Europe, where permitted by applicable rules, procedures and regulatory authorities. The RAP protocol allows for rucaparib treatment of an individual patient with third-line or greater BRCA mutant epithelial, fallopian tube, or primary peritoneal ovarian cancer who has platinum-sensitive disease and is unable to tolerate further platinum-based chemotherapy or has platinum-resistant disease and needs treatment with single agent rucaparib. The RAP protocol will also provide access to rucaparib for maintenance therapy of an individual patient with recurrent epithelial ovarian, fal

CHMP Grants Positive Opinion for Clovis Oncology’s Rubraca® (rucaparib) Tablets23.3.2018 12:50Pressemelding

Clovis Oncology, Inc. (NASDAQ: CLVS) today announced that the European Union’s (EU) European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the granting of a conditional marketing authorization for Rubraca as monotherapy treatment of adult patients with platinum sensitive, relapsed or progressive, BRCA mutated (germline and/or somatic), high-grade epithelial ovarian, fallopian tube, or primary peritoneal cancer, who have been treated with two or more prior lines of platinum based chemotherapy, and who are unable to tolerate further platinum based chemotherapy. The European Marketing Authorization application for the treatment indication was based on objective response rate and duration of response results from two multicenter, single-arm, open-label clinical trials, Study 10 and ARIEL2, in women with advanced BRCA mutant ovarian cancer who had progressed after two or more prior chemotherapies. “The recommendation

Janssen Announces Positive CHMP Opinion for JULUCATM▼ (dolutegravir/rilpivirine)23.3.2018 12:46Pressemelding

The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a Positive Opinion recommending marketing authorisation for JULUCA™ (dolutegravir 50mg [ViiV Healthcare UK Ltd]/rilpivirine 25mg [Janssen Sciences Ireland UC]). Dolutegravir/rilpivirine is a single-pill, two-drug regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults who are virologically suppressed (HIV-1 RNA <50 c/mL) on a stable antiretroviral regimen for at least six months with no history of virological failure and no known or suspected resistance to any non-nucleoside reverse transcriptase inhibitor (NNRTI) or integrase strand transfer inhibitor (INSTI).1 “We are delighted to be one step closer to bringing JULUCA™ to people living with HIV in Europe,” said Mathai Mammen, M.D., Ph.D., Global Head, Janssen Research & Development, LLC. “Building on our 25-year c

Aitheon Executives Educate World Leaders on Benefits, Challenges of AI at the Annual World Government Summit in Dubai23.3.2018 12:00Pressemelding

Aitheon, makers of the world’s first blockchain-powered platform to solve real problems by integrating AI, robotics, IoT, human specialists and cryptocurrency, announced today that executives from the company held a series of high-level briefings with world leaders at the Annual World Government Summit in Dubai. Briefings covered the benefits and challenges of AI, and revolutionary new solutions to world challenges made possible by transformative new technologies. (Read the full release at This press release features multimedia. View the full release here: Aitheon founder and CEO, Andrew Archer, and Chief Strategy Officer, Ryan Burleson, were invited to brief leaders at the Summit by Cyrus Hodes, Co-founder and Director of the AI Initiative, an undertaking of the Future Society at Harvard University’s Kennedy School. Archer and Burleson addressed a variety of AI-related topics, including the impact of AI on